Abstract
1 To evaluate the relationship between the clinical response and enhancement of GABAergic neurotransmission, for 6 months we administered vigabatrin (γ-vinyl-GABA, GVG) to 75 patients with complex partial epilepsy. Total GABA (TGABA), free GABA (FGABA), homocarnosine (HC), and GVG concentrations were measured in CSF of these patients before and during GVG treatment.
2 Over 50% reduction in seizures was found in 55% of the patients. Dose-reduction resulted in a relapse, i.e. the return of seizures.
3 At baseline TGABA, FGABA, and HC did not differ in responders and nonresponders. After GVG treatment, the TGABA and HC levels were lower in nonresponders (P < 0.001), but the GVG and FGABA levels did not differ. The GVG dose reduction resulted in a concomitant decrease in TGABA, FGABA, HC and GVG (P < 0.001).
4 According to our results GVG is an effective anticonvulsant drug in complex partial seizures. In nonresponders the poor anticonvulsant response may be related to the lower elevation of the CSF markers of GABAergic neuronal activity in this group compared with the responders.
Keywords: vigabatrin, GABA, epilepsy
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Engel J., Jr, Brown W. J., Kuhl D. E., Phelps M. E., Mazziotta J. C., Crandall P. H. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol. 1982 Dec;12(6):518–528. doi: 10.1002/ana.410120604. [DOI] [PubMed] [Google Scholar]
- Fonnum F., Søreide A., Kvale I., Walker J., Walaas I. Glutamate in cortical fibers. Adv Biochem Psychopharmacol. 1981;27:29–41. [PubMed] [Google Scholar]
- Grove J., Palfreyman M. G., Schechter P. J. Cerebrospinal fluid GABA as an index of brain GABA activity. Clin Neuropharmacol. 1983;6(3):223–229. doi: 10.1097/00002826-198309000-00004. [DOI] [PubMed] [Google Scholar]
- Hammond E. J., Wilder B. J. Gamma-vinyl GABA: a new antiepileptic drug. Clin Neuropharmacol. 1985;8(1):1–12. doi: 10.1097/00002826-198503000-00001. [DOI] [PubMed] [Google Scholar]
- Kutt H., Solomon G. E. Phenytoin: relevant side effects. Adv Neurol. 1980;27:435–445. [PubMed] [Google Scholar]
- McNamara J. O., Rigsbee L. C., Galloway M. T. Evidence that Substantia Nigra is crucial to neural network of kindled seizures. Eur J Pharmacol. 1983 Jan 21;86(3-4):485–486. doi: 10.1016/0014-2999(83)90202-9. [DOI] [PubMed] [Google Scholar]
- Schechter P. J., Hanke N. F., Grove J., Huebert N., Sjoerdsma A. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy. Neurology. 1984 Feb;34(2):182–186. doi: 10.1212/wnl.34.2.182. [DOI] [PubMed] [Google Scholar]
- Sivenius M. R., Ylinen A., Murros K., Matilainen R., Riekkinen P. Double-blind dose reduction study of vigabatrin in complex partial epilepsy. Epilepsia. 1987 Nov-Dec;28(6):688–692. doi: 10.1111/j.1528-1157.1987.tb03701.x. [DOI] [PubMed] [Google Scholar]
- Turski L., Cavalheiro E. A., Turski W. A., Meldrum B. S. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience. 1986 May;18(1):61–77. doi: 10.1016/0306-4522(86)90179-x. [DOI] [PubMed] [Google Scholar]
- van Gelder N. M., Janjua N. A., Metrakos K., MacGibbon B., Metrakos J. D. Plasma amino acids in 3/sec spike-wave epilepsy. Neurochem Res. 1980 Jun;5(6):659–671. doi: 10.1007/BF00964787. [DOI] [PubMed] [Google Scholar]